Vycor Medical (VYCO) Non Operating Income (2010 - 2026)
Vycor Medical's (VYCO) quarterly Non Operating Income came in at -$25713.0 in Q1 2026, little changed year-on-year from -$25718.0 in Q1 2025, and up 0.55% on a QoQ basis from -$25854.0 in Q4 2025.
Vycor Medical (VYCO) Non Operating Income (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Non Operating Income data on file, last reported at -$25713.0 in Q1 2026.
- On a quarterly basis, Non Operating Income changed 0.02% year-over-year to -$25713.0 in Q1 2026; TTM through Mar 2026 was -$104095.0, a 1.52% decrease from a year earlier, with the FY2025 full-year figure at -$104090.0, down 6.42% from the prior year.
- Non Operating Income for Q1 2026 stood at -$25713.0, up from -$25854.0 in the prior quarter.
- Over the last five years, Non Operating Income for VYCO reached as high as -$20898.0 in Q1 2022 and fell as low as -$27095.0 in Q3 2025.
- Historically, Non Operating Income has averaged -$24945.4 across 5 years, with a median of -$25708.0 in 2025.
- Across the five-year window, Non Operating Income sank 125.26% in 2022 and advanced 18.19% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$24674.0 in 2022, then decreased by 4.99% to -$25905.0 in 2023, then dropped by 0.48% to -$26029.0 in 2024, then increased by 0.67% to -$25854.0 in 2025, then gained by 0.55% to -$25713.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$25713.0 in Q1 2026, -$25854.0 in Q4 2025, and -$27095.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | -25,713.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,713.00 |
| Dec 31, 2025 | -25,854.00 |
| Sep 30, 2025 | -27,095.00 |
| Jun 30, 2025 | -25,433.00 |
| Mar 31, 2025 | -25,708.00 |
| Dec 31, 2024 | -26,029.00 |
| Sep 30, 2024 | -24,635.00 |
| Jun 30, 2024 | -26,167.00 |
| Mar 31, 2024 | -20,975.00 |
| Dec 31, 2023 | -25,905.00 |
| Sep 30, 2023 | -25,998.00 |
| Jun 30, 2023 | -25,729.00 |
| Mar 31, 2023 | -25,639.00 |
| Dec 31, 2022 | -24,674.00 |
| Sep 30, 2022 | -24,267.00 |
| Jun 30, 2022 | -23,352.00 |
| Mar 31, 2022 | -20,898.00 |
| Dec 31, 2021 | -21,906.00 |
| Sep 30, 2021 | 96,055.00 |
| Jun 30, 2021 | -22,546.00 |